- Investing Ideas
- /
- Hong Kong Undervalued Stocks Based On Cash Flows
Hong Kong Undervalued Stocks Based On Cash Flows
Results
30
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
30 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
596 | HK$2.89 | -3.7% | 3.2% | HK$3.5b | HK$5.00 | PE15x | E38.0% | 1.0% | Software | ||
1119 | HK$2.18 | -5.6% | -37.7% | HK$3.7b | HK$4.84 | PS1.7x | E104.1% | n/a | Media | ||
285 | HK$27.70 | -9.2% | -8.7% | HK$66.0b | HK$43.51 | PE14.2x | E22.3% | 2.1% | Tech | ||
2160 | HK$0.72 | -1.4% | -65.6% | HK$1.8b | HK$2.19 | PS4.7x | E98.6% | n/a | Healthcare | ||
2013 | HK$1.16 | -0.9% | -71.8% | HK$3.7b | HK$2.32 | PS1.5x | E109.9% | n/a | Software | ||
3393 | HK$5.77 | -10.0% | 94.3% | HK$6.3b | HK$6.90 | PE10.1x | E25.8% | 4.9% | Tech | ||
1382 | HK$1.61 | -4.7% | -17.4% | HK$2.4b | HK$3.32 | PE13.4x | E37.7% | 7.5% | Consumer Durables | ||
1801 | HK$39.95 | 6.8% | 37.5% | HK$63.9b | HK$55.92 | PS9.6x | E50.5% | n/a | Pharmaceuticals & Biotech | ||
3998 | HK$3.85 | 1.9% | 10.0% | HK$42.8b | HK$5.58 | PE12.6x | E12.8% | 6.5% | Consumer Durables | ||
973 | HK$33.95 | 0.1% | 33.7% | HK$49.9b | HK$33.58 | PE62.8x | E25.6% | 0% | Household | ||
1911 | HK$7.27 | 0% | -26.2% | HK$4.1b | HK$12.69 | PS2.6x | E97.8% | 5.7% | Diversified Financials | ||
9886 | HK$1.00 | 4.2% | -64.2% | HK$1.4b | HK$1.56 | PB0.6x | E84.4% | n/a | Consumer Retailing | ||
1548 | HK$11.90 | -3.6% | -37.5% | HK$25.2b | HK$24.14 | PS3.9x | E97.9% | 0% | Pharmaceuticals & Biotech | ||
799 | HK$2.63 | -2.6% | -32.9% | HK$3.1b | HK$4.22 | PE40.8x | E51.2% | n/a | Media | ||
2325 | HK$8.40 | -5.6% | -31.4% | HK$5.0b | HK$13.99 | PS5.2x | E97.8% | 0.2% | Healthcare | ||
6616 | HK$3.81 | -2.8% | -14.8% | HK$4.8b | HK$5.83 | PE23.9x | E41.8% | 0% | Materials | ||
2400 | HK$21.30 | -4.3% | 17.2% | HK$10.6b | HK$20.17 | PS2.7x | E56.8% | n/a | Media | ||
1952 | HK$18.84 | -0.4% | 4.4% | HK$6.2b | HK$26.07 | PS44x | E76.3% | n/a | Pharmaceuticals & Biotech | ||
9923 | HK$10.64 | -4.8% | -41.0% | HK$4.7b | HK$15.72 | PE359.7x | E51.5% | n/a | Diversified Financials | ||
1516 | HK$1.65 | -3.5% | -32.1% | HK$5.2b | HK$1.87 | PB0.8x | E60.4% | 9.4% | Real Estate Management and Development | ||
1821 | HK$11.02 | -5.3% | -14.2% | HK$48.5b | HK$15.43 | PE29.3x | E26.3% | 2.2% | Real Estate Management and Development | ||
2382 | HK$39.55 | -10.7% | -44.7% | HK$45.7b | HK$65.72 | PE35.9x | E24.6% | 0.6% | Tech | ||
2276 | HK$10.74 | -5.1% | 114.4% | HK$4.9b | HK$13.41 | PE12.9x | E16.1% | 2.0% | Healthcare | ||
3908 | HK$8.35 | 2.0% | -52.4% | HK$110.7b | HK$12.95 | PE8.3x | E20.0% | 2.3% | Diversified Financials |